Features Screener Stocks Charts
Sign In Sign Up

Strides Arcolab Ltd. Income Statement

NSE:STAR | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year STAR income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 40.91B 46.24B
Cost of Revenue -16.41B -19.80B
Gross Profit 24.50B 26.44B
Sales, General & Admin -16.67B -17.83B
Operating Income 5.62B 6.69B
Profit Before Tax -1.17B 4.87B
Net Income -943.14M 35.98B
Diluted Shares 90.88M 92.02M
Diluted EPS -7.77 390.50

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025